Fetal Monitoring
Conditions
Keywords
Fetal monitoring, antenatal testing
Brief summary
The goal of this clinical trial is to determine the effectiveness of remote nonstress test (NST) compared to in-clinic NSTs in improving fetal testing completion rates. Participants will be randomized to either in-clinic NSTs or use of an FDA-approved remote monitoring belt for their pregnancy monitoring.
Interventions
INVU monitoring belt used for remote NSTs
In-clinic NSTs - standard of care
Sponsors
Study design
Eligibility
Inclusion criteria
* Singleton pregnancy * Gestational age between 30 weeks 0 days and 35 weeks 6 days * Pregnant patients who have clinical indication for fetal surveillance with NSTs (based on UPHS Health System clinical guidelines for antenatal monitoring) * Able to provide written consent * English speaking
Exclusion criteria
* Multiple gestations * Maternal pre-gravid BMI greater than 45kg/m2 * Presence of an implanted pacemaker or defibrillator * Active abdominal skin infection * A known amniotic fluid index (AFI) less than 5cm or greater than 25cm on the most recent ultrasound (if available) prior to randomization * Delivery is planned within 2 weeks of potential randomization
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Overall Fetal Testing Completion Rate | from 32 weeks gestational age to delivery, average of 10 weeks after enrollment. | percentage of recommended antenatal testing sessions that were successfully completed as defined as a clinically interpreted test was performed |
| Fetal Testing Completion Rate in Black versus non-Black subjects | from 32 weeks gestational age to delivery, average of 10 weeks after enrollment. | Comparison between Black and non-Black subjects' percentage of recommended antenatal testing sessions that were successfully completed as defined as a clinically interpreted test was performed. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Obstetrics outcomes: Mode of delivery | time of delivery | categorized as vaginal or cesarean |
| Fetal Monitoring outcomes: Number of visits to the antenatal testing unit | from 32 weeks gestational age to delivery, average of 10 weeks after enrollment. | Count of visits to the office for in-person monitoring |
| Fetal Monitoring outcomes: Frequency of provider recommended prolonged monitoring | from 32 weeks gestational age to delivery, average of 10 weeks after enrollment. | Count of number of times provider recommends prolonged monitoring (defined by greater than 40 minutes of time on the monitor). |
| Fetal Monitoring outcomes: Time on NST monitor | from 32 weeks gestational age to delivery, average of 10 weeks after enrollment. | Sum of the number of minutes the subject is on the NST monitor |
| Fetal Monitoring outcomes: Number of non-reactive NSTs | from 32 weeks gestational age to delivery, average of 10 weeks after enrollment. | Count of the number of visits |
| Fetal Monitoring outcomes: Number of biophysical profiles performed for non-reactive NST tests | from 32 weeks gestational age to delivery, average of 10 weeks after enrollment. | Count of the number of biophysical profiles performed for non-reactive NST visits |
| Fetal Monitoring outcomes: Overall number of visits to the obstetrical triage unit | from 32 weeks gestational age to delivery, average of 10 weeks after enrollment. | Count of the number of visits to the obstetrical triage unit |
| Fetal Monitoring outcomes: Overall number of visits to the obstetrical triage unit directly related to a fetal monitoring visit | from 32 weeks gestational age to delivery, average of 10 weeks after enrollment. | Count of the number of visit directly related to an outpatient fetal monitoring appointment or session |
| Fetal Monitoring outcomes: Frequency of recommendation for delivery based on findings on fetal monitoring result | from 32 weeks gestational age to delivery, average of 10 weeks after enrollment. | Count of the number of subjects in each arm who receive a recommendation for delivery based on the findings of the fetal monitoring results. |
| Fetal Monitoring outcomes: Number of times a NST is not completed within the prescribed window | from 32 weeks gestational age to delivery, average of 10 weeks after enrollment. | Count of number of NSTs which occur outside of prescribed window, for example, if a weekly testing regimen is prescribed, an appointment 8 or more days following the last one would count as 1 missed calendar window. |
| Obstetrics outcomes: Number of participants with an Indication for labor induction | time of labor induction | in subjects who have labor induction, indication for inducing labor |
| Obstetrics outcomes: Gestational age at delivery | time of delivery | gestational age at time of delivery |
| Obstetrics outcomes: Composite neonatal morbidity score | from delivery to 6 weeks post-delivery | Composite score of neonatal morbidity comprised of one or more of the following: severe respiratory distress, neonatal resuscitation outside of the delivery room, and death. This score could range from 0 to 3 with a higher score meaning a worse outcome |
| Obstetrics outcomes: Neonatal cord blood pH | time of delivery | — |
| Obstetrics outcomes: Apgar scores | five and ten minutes after delivery | Apgar score at five and ten minutes after delivery, the score ranges from 0 to 10 with a higher score meaning a better outcome. |
| Obstetrics outcomes: Number of participants with an Admission to the neonatal intensive care unit | from delivery to 6 weeks post-delivery | — |
| Obstetrics outcomes: Admission to the neonatal intensive care unit for greater than 48 hours | from delivery to 6 weeks post-delivery | — |
| Obstetrics outcomes: Maternal length of stay | from delivery to discharge, up to 6 weeks post-delivery | — |
| Obstetrics outcomes: Neonatal length of stay | from birth to discharge, up to 6 weeks after birth | — |
| Cost-effectiveness outcomes: Productivity loss survey | at three timepoints, at time of randomization, 3 weeks after randomization (plus or minus 1 week) and 5 weeks after randomization (plus or minus 1 week) | This survey will collect in half days increments the productivity impacts of the pregnancy, NSTs and for seeking health care for those reasons |
| Cost-effectiveness outcomes: Costs | from 32 weeks to delivery, average of 10 weeks after enrollment. | Costs will be estimated based on collection of data on all health care visits, including outpatient, ED, OB triage and hospital admissions |
| Implementation outcomes: Theory-informed Acceptability Questionnaire | at time of delivery | 8-item Likert scale with range of values from 8 to 40 with a high score being more acceptable. |
| Obstetrics outcomes: Number of participants with an Indication for cesarean section | time of delivery | in subjects who have a cesarean section delivery, indication for cesarean section |
| Obstetrics outcomes: Number of participants with Preterm delivery | time of delivery | preterm delivery is defined as less than 37 weeks gestational age |
Countries
United States